9-Hydroxyellipticine alters the conformation and DNA binding characteristics of mutated p53 protein

Anticancer Research

Volumn 21, Issue 4 A, 2001, Pages 2671-2675

  Sugikawa, E ^a   Tsunoda, S ^a   Nakanishi, N ^a   Ohashi, M ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

9 Hydroxyellipticine; Conformation; Cytotoxic agents; DNA binding characteristics; Mutated p53

Indexed keywords

9 HYDROXYELLIPTICINE; CALPAIN; PROTEIN P53;

AMINO ACID SEQUENCE; ARTICLE; BREAST CARCINOMA; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA BINDING; DRUG ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN TERTIARY STRUCTURE; STOMACH CARCINOMA;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CALPAIN; CONSENSUS SEQUENCE; DNA; ELLIPTICINES; HUMANS; NEOPLASMS; POINT MUTATION; PROTEIN CONFORMATION; SALMON; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035155808     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. p53 function and dysfunction
2. Mutations in the p53 gene occur in diverse human tumour types
3. p53 mutations in human cancers
4. The p53 tumour suppressor gene
5. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
6. Synthesis and antitumor activity of ellipticine alkaloids and related compounds
7. Mutant p53-mediated induction of cell cycle arrest and apoptosis at G-phase by 9-hydroxyellipticine
8. Proteolytic cleavage of human p53 by calpain: A potential regulator of protein stability
9. Proteolysis by calpains: A possible contribution to degradation of p53
10. Abrogation of p53-mediated transactivation by SV 40 large T antigen
11. Direct sequencing from touch preparations of human carcinomas:analysis of p53 mutations in breast carcinomas
12. p53 mutations, ras mutations and p53-heat shock 70 protein complexes in human lung carcinoma cell lines
13. p53 gene mutations in gastric cancer metastases in gastric cancer cell lines derived from metastases
14. Missense mutations and a deletion of the p53 gene in human gastric cancer
15. p53 oncogene mutations in three human prostate cancer cell lines
16. Analysis of molecular mechanism in colorectal tumorigenesis
17. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin
18. Addition of fresh medium induces cell cycle and conformation change in p 53, a tumor suppressor protein
19. Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells
20. Alteration of p53 conformation and induction of apoptosis in a murine erythroleukemia cell line by dimethylsulfoxide
21. Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: A possible anticancer mechanism
22. Interaction of heat-shock protein 70 with p53 translated in vitro: Evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation
23. Histone deacetylase inhibitor activates the WAF1/Cipl gene promoter through the Spl sites